Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: DRUG THERAPY, COMBINATION - METHODS , . Treffer: 13
2021
Holzmann, C; Witt, M; Rolfs, A; Antipova, V; Wree, A
Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1
INT J MOL SCI. 2021; 22(5): 2539
Doi: 10.3390/ijms22052539
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Fontana, RJ; Brown, RS; Moreno-Zamora, A; Prieto, M; Joshi, S; Londoño, MC; Herzer, K; Chacko, KR; Stauber, RE; Knop, V; Jafri, SM; Castells, L; Ferenci, P; Torti, C; Durand, CM; Loiacono, L; Lionetti, R; Bahirwani, R; Weiland, O; Mubarak, A; ElSharkawy, AM; Stadler, B; Montalbano, M; Berg, C; Pellicelli, AM; Stenmark, S; Vekeman, F; Ionescu-Ittu, R; Emond, B; Reddy, KR
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
Liver Transpl. 2016; 22(4):446-458
Doi: 10.1002/lt.24416
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Stachon, P; Ahrens, I; Bode, C; Zirlik, A
Dual pathway therapy in acute coronary syndrome.
J THROMB THROMBOLYS. 2016; 42(2): 254-260.
Doi: 10.1007/s11239-015-1306-3
Web of Science
PubMed
FullText
FullText_MUG
2015
Pieber, TR; Deller, S; Korsatko, S; Jensen, L; Christiansen, E; Madsen, J; Heller, SR
Counter-regulatory hormone responses to hypoglycaemia in people with type 1 diabetes after 4 weeks of treatment with liraglutide adjunct to insulin: a randomized, placebo-controlled, double-blind, crossover trial.
Diabetes Obes Metab. 2015; 17(8):742-750
Doi: 10.1111/dom.12473
Web of Science
PubMed
FullText
FullText_MUG
Skrabl-Baumgartner, A; Weger, W; Salmhofer, W; Jahnel, J
Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
Pediatr Dermatol. 2015; 32(1):e13-e14
Doi: 10.1111/pde.12457
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
2014
Mandorfer, M; Payer, BA; Niederecker, A; Lang, G; Aichelburg, MC; Strassl, R; Boesecke, C; Rieger, A; Trauner, M; Peck-Radosavljevic, M; Reiberger, T
Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.
AIDS Patient Care STDS. 2014; 28(5): 221-227.
Doi: 10.1089/apc.2013.0359
Web of Science
PubMed
FullText
FullText_MUG
Mandorfer, M; Reiberger, T; Payer, BA; Breitenecker, F; Aichelburg, MC; Obermayer-Pietsch, B; Rieger, A; Puoti, M; Zangerle, R; Trauner, M; Peck-Radosavljevic, M
Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.
J Viral Hepat. 2014; 21(1):33-41
Doi: 10.1111/jvh.12118
Web of Science
PubMed
FullText
FullText_MUG
Nucci, M; Marr, KA; Vehreschild, MJ; de Souza, CA; Velasco, E; Cappellano, P; Carlesse, F; Queiroz-Telles, F; Sheppard, DC; Kindo, A; Cesaro, S; Hamerschlak, N; Solza, C; Heinz, WJ; Schaller, M; Atalla, A; Arikan-Akdagli, S; Bertz, H; Galvão Castro, C; Herbrecht, R; Hoenigl, M; Härter, G; Hermansen, NE; Josting, A; Pagano, L; Salles, MJ; Mossad, SB; Ogunc, D; Pasqualotto, AC; Araujo, V; Troke, PF; Lortholary, O; Cornely, OA; Anaissie, E
Improvement in the outcome of invasive fusariosis in the last decade.
Clin Microbiol Infect. 2014; 20(6):580-585
Doi: 10.1111/1469-0691.12409
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Razavi, H; Waked, I; Sarrazin, C; Myers, RP; Idilman, R; Calinas, F; Vogel, W; Mendes Correa, MC; Hézode, C; Lázaro, P; Akarca, U; Aleman, S; Balık, I; Berg, T; Bihl, F; Bilodeau, M; Blasco, AJ; Brandão Mello, CE; Bruggmann, P; Buti, M; Calleja, JL; Cheinquer, H; Christensen, PB; Clausen, M; Coelho, HS; Cramp, ME; Dore, GJ; Doss, W; Duberg, AS; El-Sayed, MH; Ergör, G; Esmat, G; Falconer, K; Félix, J; Ferraz, ML; Ferreira, PR; Frankova, S; García-Samaniego, J; Gerstoft, J; Giria, JA; Gonçales, FL; Gower, E; Gschwantler, M; Guimarães Pessôa, M; Hindman, SJ; Hofer, H; Husa, P; Kåberg, M; Kaita, KD; Kautz, A; Kaymakoglu, S; Krajden, M; Krarup, H; Laleman, W; Lavanchy, D; Marinho, RT; Marotta, P; Mauss, S; Moreno, C; Murphy, K; Negro, F; Nemecek, V; Örmeci, N; Øvrehus, AL; Parkes, J; Pasini, K; Peltekian, KM; Ramji, A; Reis, N; Roberts, SK; Rosenberg, WM; Roudot-Thoraval, F; Ryder, SD; Sarmento-Castro, R; Semela, D; Sherman, M; Shiha, GE; Sievert, W; Sperl, J; Stärkel, P; Stauber, RE; Thompson, AJ; Urbanek, P; Van Damme, P; van Thiel, I; Van Vlierberghe, H; Vandijck, D; Wedemeyer, H; Weis, N; Wiegand, J; Yosry, A; Zekry, A; Cornberg, M; Müllhaupt, B; Estes, C
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.
J Viral Hepat. 2014; 21 Suppl 1(41):34-59
Doi: 10.1111/jvh.12248
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wedemeyer, H; Duberg, AS; Buti, M; Rosenberg, WM; Frankova, S; Esmat, G; Örmeci, N; Van Vlierberghe, H; Gschwantler, M; Akarca, U; Aleman, S; Balık, I; Berg, T; Bihl, F; Bilodeau, M; Blasco, AJ; Brandão Mello, CE; Bruggmann, P; Calinas, F; Calleja, JL; Cheinquer, H; Christensen, PB; Clausen, M; Coelho, HS; Cornberg, M; Cramp, ME; Dore, GJ; Doss, W; El-Sayed, MH; Ergör, G; Estes, C; Falconer, K; Félix, J; Ferraz, ML; Ferreira, PR; García-Samaniego, J; Gerstoft, J; Giria, JA; Gonçales, FL; Guimarães Pessôa, M; Hézode, C; Hindman, SJ; Hofer, H; Husa, P; Idilman, R; Kåberg, M; Kaita, KD; Kautz, A; Kaymakoglu, S; Krajden, M; Krarup, H; Laleman, W; Lavanchy, D; Lázaro, P; Marinho, RT; Marotta, P; Mauss, S; Mendes Correa, MC; Moreno, C; Müllhaupt, B; Myers, RP; Nemecek, V; Øvrehus, AL; Parkes, J; Peltekian, KM; Ramji, A; Razavi, H; Reis, N; Roberts, SK; Roudot-Thoraval, F; Ryder, SD; Sarmento-Castro, R; Sarrazin, C; Semela, D; Sherman, M; Shiha, GE; Sperl, J; Stärkel, P; Stauber, RE; Thompson, AJ; Urbanek, P; Van Damme, P; van Thiel, I; Vandijck, D; Vogel, W; Waked, I; Weis, N; Wiegand, J; Yosry, A; Zekry, A; Negro, F; Sievert, W; Gower, E
Strategies to manage hepatitis C virus (HCV) disease burden.
J Viral Hepat. 2014; 21 Suppl 1(41):60-89
Doi: 10.1111/jvh.12249
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Mandorfer, M; Neukam, K; Reiberger, T; Payer, BA; Rivero, A; Puoti, M; Boesecke, C; Baumgarten, A; Grzeszczuk, A; Zangerle, R; Meyer-Olson, D; Rockstroh, JK; Trauner, M; Pineda, JA; Peck-Radosavljevic, M
The impact of interleukin 28B rs12979860 single nucleotide polymorphism and liver fibrosis stage on response-guided therapy in HIV/HCV-coinfected patients.
AIDS. 2013; 27(17): 2707-2714.
Doi: 10.1097/01.aids.0000432460.44593.ef
Web of Science
PubMed
FullText
FullText_MUG
2010
Lampl, C; Schweiger, C; Haider, B; Lechner, A
Pregabalin as mono- or add-on therapy for patients with refractory chronic neuropathic pain: a post-marketing prescription-event monitoring study.
J Neurol. 2010; 257(8):1265-1273
Doi: 10.1007/s00415-010-5504-9
Web of Science
PubMed
FullText
FullText_MUG
1980
Fellinger, C; Bartl, G
Clinical experience with different methods of treating herpes corneae (author's transl)
Klin Monatsbl Augenheilkd. 1980; 176(2):239-241
Doi: 10.1055/s-2008-1057435
Web of Science
PubMed
FullText
FullText_MUG